['chronic lymphocytic leukemia']
['tgr-1202 + obinutuzumab + chlorambucil']

        Inclusion Criteria:

          -  Confirmed Chronic Lymphocytic Leukemia (CLL)

          -  Eastern Cooperative Oncology Group (ECOG) score of 0 to 2

          -  Ability to swallow oral medication

        Exclusion Criteria:

          -  Known hepatitis B virus, hepatitis C virus or HIV infection

          -  Primary central nervous system lymphoma or known intracranial involvement

          -  Autologous hematologic stem cell transplant within 3 months of study entry or
             Allogeneic hematologic stem cell transplant within 12 months
      